{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:36:13Z","timestamp":1794072973604,"version":"4.8.0"},"reference-count":43,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The most significant complication in hemophilia A treatment is the formation of inhibitors against factor VIII (FVIII) protein. Glycans and glycan-binding proteins are central to a properly functioning immune system. This study focuses on whether glycosylation of FVIII plays an important role in induction and regulation of anti-FVIII immune responses. We investigated the potential roles of 4 N-glycosylation sites, including N41 and N239 in the A1 domain, N1810 in the A3 domain, and N2118 in the C1 domain of FVIII, in moderating its immunogenicity. Glycomics analysis of plasma-derived FVIII revealed that sites N41, N239, and N1810 contain mostly sialylated complex glycoforms, while high mannose glycans dominate at site N2118. A missense variant that substitutes asparagine (N) to glutamine (Q) was introduced to eliminate glycosylation on each of these sites. Following gene transfer of plasmids encoding B domain deleted FVIII (BDD-FVIII) and each of these 4 FVIII variants, it was found that specific activity of FVIII in plasma remained similar among all treatment groups. Slightly increased or comparable immune responses in N41Q, N239Q, and N1810Q FVIII variant plasmid-treated mice and significantly decreased immune responses in N2118Q FVIII plasmid-treated mice were observed when compared with BDD-FVIII plasmid-treated mice. The reduction of inhibitor response by N2118Q FVIII variant was also demonstrated in AAV-mediated gene transfer experiments. Furthermore, a specific glycopeptide epitope surrounding the N2118 glycosylation site was identified and characterized to activate T cells in an FVIII-specific proliferation assay. These results indicate that N-glycosylation of FVIII can have significant impact on its immunogenicity.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005758","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T17:20:39Z","timestamp":1651771239000},"page":"4271-4282","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":16,"title":["Influence of N-glycosylation in the A and C domains on the immunogenicity of factor VIII"],"prefix":"10.1182","volume":"6","author":[{"given":"Amber","family":"Vander Kooi","sequence":"first","affiliation":[{"name":"1Center for Immunity and Immunotherapies, Seattle Children\u2019s Research Institute, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaishuai","family":"Wang","sequence":"additional","affiliation":[{"name":"2Department of Chemistry, Georgia State University, Atlanta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ni","family":"Fan","sequence":"additional","affiliation":[{"name":"1Center for Immunity and Immunotherapies, Seattle Children\u2019s Research Institute, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Chen","sequence":"additional","affiliation":[{"name":"1Center for Immunity and Immunotherapies, Seattle Children\u2019s Research Institute, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Zhang","sequence":"additional","affiliation":[{"name":"3School of Medicines, Indiana University, Bloomington, IN; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7199-3271","authenticated-orcid":false,"given":"Chun-Yu","family":"Chen","sequence":"additional","affiliation":[{"name":"1Center for Immunity and Immunotherapies, Seattle Children\u2019s Research Institute, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Cai","sequence":"additional","affiliation":[{"name":"1Center for Immunity and Immunotherapies, Seattle Children\u2019s Research Institute, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Konkle","sequence":"additional","affiliation":[{"name":"4Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9300-980X","authenticated-orcid":false,"given":"Weidong","family":"Xiao","sequence":"additional","affiliation":[{"name":"3School of Medicines, Indiana University, Bloomington, IN; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1146-0761","authenticated-orcid":false,"given":"Lei","family":"Li","sequence":"additional","affiliation":[{"name":"2Department of Chemistry, Georgia State University, Atlanta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6520-2373","authenticated-orcid":false,"given":"Carol H.","family":"Miao","sequence":"additional","affiliation":[{"name":"1Center for Immunity and Immunotherapies, Seattle Children\u2019s Research Institute, Seattle, WA;"},{"name":"5Department of Pediatrics, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"issue":"7","key":"2022072215253162100_B1","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1538-7836.2004.00710.x","article-title":"The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99","volume":"2","author":"Darby","year":"2004","journal-title":"J Thromb Haemost."},{"key":"2022072215253162100_B2","first-page":"1","article-title":"Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patients","volume":"31","author":"Hoyer","year":"1994","journal-title":"Semin Hematol."},{"key":"2022072215253162100_B3","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3389\/fimmu.2019.02991","article-title":"Tolerating factor VIII: recent progress","volume":"10","author":"Lacroix-Desmazes","year":"2020","journal-title":"Front Immunol."},{"issue":"24","key":"2022072215253162100_B4","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1182\/blood-2016-11-750885","article-title":"Biological considerations of plasma-derived and recombinant factor VIII immunogenicity","volume":"129","author":"Lai","year":"2017","journal-title":"Blood."},{"issue":"1","key":"2022072215253162100_B5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jth.13888","article-title":"Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis","volume":"16","author":"Peyvandi","year":"2018","journal-title":"J Thromb Haemost."},{"issue":"11","key":"2022072215253162100_B6","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3324\/haematol.2018.188219","article-title":"N-linked glycosylation modulates the immunogenicity of recombinant human factor VIII in hemophilia A mice","volume":"103","author":"Lai","year":"2018","journal-title":"Haematologica."},{"key":"2022072215253162100_B7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cellimm.2015.12.008","article-title":"Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice","volume":"301","author":"Krishnamoorthy","year":"2016","journal-title":"Cell Immunol."},{"issue":"1","key":"2022072215253162100_B8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.thromres.2012.09.011","article-title":"Characterisation of the post-translational modifications of a novel, human cell line-derived recombinant human factor VIII","volume":"131","author":"Kannicht","year":"2013","journal-title":"Thromb Res."},{"issue":"8","key":"2022072215253162100_B9","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/jth.14204","article-title":"In-depth comparison of N-glycosylation of human plasma-derived factor VIII and different recombinant products: from structure to clinical implications","volume":"16","author":"Canis","year":"2018","journal-title":"J Thromb Haemost."},{"issue":"5","key":"2022072215253162100_B10","doi-asserted-by":"crossref","first-page":"e0233576","DOI":"10.1371\/journal.pone.0233576","article-title":"Comparative glycosylation mapping of plasma-derived and recombinant human factor VIII","volume":"15","author":"Qu","year":"2020","journal-title":"PLoS One."},{"issue":"12","key":"2022072215253162100_B11","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1073\/pnas.1507706113","article-title":"Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells","volume":"113","author":"Perdicchio","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"issue":"12","key":"2022072215253162100_B12","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3324\/haematol.2012.063297","article-title":"Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5","volume":"97","author":"Pegon","year":"2012","journal-title":"Haematologica."},{"issue":"6","key":"2022072215253162100_B13","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1538-7836.2005.01389.x","article-title":"The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor","volume":"3","author":"Bovenschen","year":"2005","journal-title":"J Thromb Haemost."},{"issue":"21","key":"2022072215253162100_B14","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1073\/pnas.0702120104","article-title":"A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes","volume":"104","author":"Dasgupta","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"2022072215253162100_B15","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.3389\/fimmu.2018.02754","article-title":"Glycans as key checkpoints of T cell activity and function","volume":"9","author":"Pereira","year":"2018","journal-title":"Front Immunol."},{"key":"2022072215253162100_B16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0065-2660(05)54007-0","article-title":"A novel gene expression system: non-viral gene transfer for hemophilia as model systems","volume":"54","author":"Miao","year":"2005","journal-title":"Adv Genet."},{"key":"2022072215253162100_B17","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3389\/fimmu.2020.00638","article-title":"A Treg-selective IL-2 mutein prevents the formation of factor VIII inhibitors in hemophilia mice treated with factor VIII gene therapy","volume":"11","author":"Chen","year":"2020","journal-title":"Front Immunol."},{"key":"2022072215253162100_B18","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.omtn.2020.03.015","article-title":"Treatment of hemophilia A using factor VIII messenger RNA lipid nanoparticles","volume":"20","author":"Chen","year":"2020","journal-title":"Mol Ther Nucleic Acids."},{"issue":"8","key":"2022072215253162100_B19","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1074\/jbc.M707137200","article-title":"Mutants of Mucor hiemalis endo-beta-N-acetylglucosaminidase show enhanced transglycosylation and glycosynthase-like activities","volume":"283","author":"Umekawa","year":"2008","journal-title":"J Biol Chem."},{"key":"2022072215253162100_B20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fped.2015.00054","article-title":"Glycans Instructing immunity: the emerging role of altered glycosylation in clinical immunology","volume":"3","author":"Lyons","year":"2015","journal-title":"Front Pediatr."},{"issue":"3","key":"2022072215253162100_B21","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1182\/blood-2007-08-109918","article-title":"The tertiary structure and domain organization of coagulation factor VIII","volume":"111","author":"Shen","year":"2008","journal-title":"Blood."},{"issue":"4","key":"2022072215253162100_B22","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1182\/blood.V99.4.1215","article-title":"3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography","volume":"99","author":"Stoilova-McPhie","year":"2002","journal-title":"Blood."},{"issue":"6","key":"2022072215253162100_B23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1367-5931(99)00021-6","article-title":"Effect of N-linked glycosylation on glycopeptide and glycoprotein structure","volume":"3","author":"Imperiali","year":"1999","journal-title":"Curr Opin Chem Biol."},{"issue":"3","key":"2022072215253162100_B24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1208\/s12248-009-9119-y","article-title":"Role of glycosylation in conformational stability, activity, macromolecular interaction and immunogenicity of recombinant human factor VIII","volume":"11","author":"Kosloski","year":"2009","journal-title":"AAPS J."},{"issue":"5","key":"2022072215253162100_B25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1042\/BCJ20170884","article-title":"Molecular mechanisms of missense mutations that generate ectopic N-glycosylation sites in coagulation factor VIII","volume":"475","author":"Wei","year":"2018","journal-title":"Biochem J."},{"issue":"21","key":"2022072215253162100_B26","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1182\/blood.V118.21.2238.2238","article-title":"Elucidation of the roles of individual asparagine-linked glycans outside of the B domain on factor VIII secretion","volume":"118","author":"Selvaraj","year":"2011","journal-title":"Blood."},{"key":"2022072215253162100_B27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3389\/fimmu.2020.00393","article-title":"Removal of mannose-ending glycan at Asn2118 abrogates FVIII presentation by human monocyte-derived dendritic cells","volume":"11","author":"Delignat","year":"2020","journal-title":"Front Immunol."},{"issue":"3","key":"2022072215253162100_B28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/jth.15616","article-title":"Removal of single-site N-linked glycans on factor VIII alters binding of domain-specific monoclonal antibodies","volume":"20","author":"Ito","year":"2022","journal-title":"J Thromb Haemost."},{"issue":"4","key":"2022072215253162100_B29","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jaci.2012.01.048","article-title":"Mannose-sensitive receptors mediate the uptake of factor VIII therapeutics by human dendritic cells","volume":"129","author":"Repess\u00e9","year":"2012","journal-title":"J Allergy Clin Immunol."},{"issue":"2","key":"2022072215253162100_B30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jaci.2011.08.029","article-title":"Uptake of blood coagulation factor VIII by dendritic cells is mediated via its C1 domain","volume":"129","author":"Herczenik","year":"2012","journal-title":"J Allergy Clin Immunol."},{"issue":"2","key":"2022072215253162100_B31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2516.2011.02679.x","article-title":"Immunoprotective effect of von Willebrand factor towards therapeutic factor VIII in experimental haemophilia A","volume":"18","author":"Delignat","year":"2012","journal-title":"Haemophilia."},{"issue":"2","key":"2022072215253162100_B32","doi-asserted-by":"crossref","first-page":"23539","DOI":"10.4172\/jpb.10000e24","article-title":"Glyco-epitope diversity: an evolving area of glycomics research and biomarker discovery","volume":"7","author":"Wang","year":"2014","journal-title":"J Proteomics Bioinform."},{"issue":"4","key":"2022072215253162100_B33","doi-asserted-by":"crossref","first-page":"e1005550","DOI":"10.1371\/journal.ppat.1005550","article-title":"The Epstein-Barr virus glycoprotein gp150 forms an immune-evasive glycan shield at the surface of infected cells","volume":"12","author":"Gram","year":"2016","journal-title":"PLoS Pathog."},{"key":"2022072215253162100_B34","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3389\/fimmu.2018.00910","article-title":"Glycan shielding and modulation of hepatitis C virus neutralizing antibodies","volume":"9","author":"Lavie","year":"2018","journal-title":"Front Immunol."},{"issue":"10","key":"2022072215253162100_B35","doi-asserted-by":"crossref","first-page":"6369","DOI":"10.4049\/jimmunol.0804287","article-title":"Proximal glycans outside of the epitopes regulate the presentation of HIV-1 envelope gp120 helper epitopes","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol."},{"issue":"1","key":"2022072215253162100_B36","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-020-16319-0","article-title":"Glycopeptide epitope facilitates HIV-1 envelope specific humoral immune responses by eliciting T cell help","volume":"11","author":"Sun","year":"2020","journal-title":"Nat Commun."},{"issue":"11","key":"2022072215253162100_B37","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1538-7836.2009.03571.x","article-title":"Splenic marginal zone antigen-presenting cells are critical for the primary allo-immune response to therapeutic factor VIII in hemophilia A","volume":"7","author":"Navarrete","year":"2009","journal-title":"J Thromb Haemost."},{"issue":"23","key":"2022072215253162100_B38","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood-2017-05-782912","article-title":"Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A","volume":"130","author":"Zerra","year":"2017","journal-title":"Blood."},{"issue":"9","key":"2022072215253162100_B39","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/jth.14233","article-title":"Anti-C1 domain antibodies that accelerate factor\u00a0VIII clearance contribute to antibody pathogenicity in a murine hemophilia\u00a0A model","volume":"16","author":"Batsuli","year":"2018","journal-title":"J Thromb Haemost."},{"issue":"2","key":"2022072215253162100_B40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/jth.13570","article-title":"Enhanced uptake of blood coagulation factor VIII containing immune complexes by antigen presenting cells","volume":"15","author":"Hartholt","year":"2017","journal-title":"J Thromb Haemost."},{"issue":"2","key":"2022072215253162100_B41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/sji.12573","article-title":"Anti-Fc\u03b3RIIB (CD32) antibodies differentially modulate murine FVIII-specific recall response in\u00a0vitro","volume":"86","author":"Vollack","year":"2017","journal-title":"Scand J Immunol."},{"key":"2022072215253162100_B42","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3389\/fimmu.2020.00905","article-title":"Fc gamma receptors and complement component 3 facilitate anti-fVIII antibody formation","volume":"11","author":"Zerra","year":"2020","journal-title":"Front Immunol."},{"issue":"9","key":"2022072215253162100_B43","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1182\/blood.2020009210","article-title":"Nonhuman glycans can regulate anti-factor VIII antibody formation in mice","volume":"139","author":"Arthur","year":"2022","journal-title":"Blood."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/14\/4271\/1909526\/advancesadv2021005758.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/14\/4271\/1909526\/advancesadv2021005758.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T15:26:32Z","timestamp":1658503592000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/14\/4271\/485173\/Influence-of-N-glycosylation-in-the-A-and-C"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":43,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2022,7,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005758","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]}}}